1. Home
  2. SVA vs ATLCP Comparison

SVA vs ATLCP Comparison

Compare SVA & ATLCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVA
  • ATLCP
  • Stock Information
  • Founded
  • SVA N/A
  • ATLCP N/A
  • Country
  • SVA
  • ATLCP United States
  • Employees
  • SVA 3261
  • ATLCP 386
  • Industry
  • SVA
  • ATLCP Finance: Consumer Services
  • Sector
  • SVA
  • ATLCP Finance
  • Exchange
  • SVA NYSE
  • ATLCP Nasdaq
  • Market Cap
  • SVA N/A
  • ATLCP N/A
  • IPO Year
  • SVA N/A
  • ATLCP N/A
  • Fundamental
  • Price
  • SVA $6.47
  • ATLCP $23.49
  • Analyst Decision
  • SVA
  • ATLCP
  • Analyst Count
  • SVA 0
  • ATLCP 0
  • Target Price
  • SVA N/A
  • ATLCP N/A
  • AVG Volume (30 Days)
  • SVA N/A
  • ATLCP N/A
  • Earning Date
  • SVA N/A
  • ATLCP N/A
  • Dividend Yield
  • SVA N/A
  • ATLCP N/A
  • EPS Growth
  • SVA N/A
  • ATLCP N/A
  • EPS
  • SVA N/A
  • ATLCP N/A
  • Revenue
  • SVA N/A
  • ATLCP N/A
  • Revenue This Year
  • SVA N/A
  • ATLCP N/A
  • Revenue Next Year
  • SVA N/A
  • ATLCP N/A
  • P/E Ratio
  • SVA N/A
  • ATLCP N/A
  • Revenue Growth
  • SVA N/A
  • ATLCP N/A
  • 52 Week Low
  • SVA N/A
  • ATLCP N/A
  • 52 Week High
  • SVA N/A
  • ATLCP N/A
  • Technical
  • Relative Strength Index (RSI)
  • SVA N/A
  • ATLCP 56.41
  • Support Level
  • SVA N/A
  • ATLCP $23.23
  • Resistance Level
  • SVA N/A
  • ATLCP $23.30
  • Average True Range (ATR)
  • SVA 0.00
  • ATLCP 0.23
  • MACD
  • SVA 0.00
  • ATLCP 0.06
  • Stochastic Oscillator
  • SVA 0.00
  • ATLCP 100.00

About SVA SINOVAC BIOTECH LTD

Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.

About ATLCP Atlanticus Holdings Corporation 7.625% Series B Cumulative Perpetual Preferred Stock no par value per share

Atlanticus Holdings Corp invests in the financial services industry. It provides various credit and related financial services and products to or associated with the financially underserved consumer credit market. The operating business segments are the Credit as a Service and the Auto Finance segment. It generates maximum revenue from the Credit as a Service segment.

Share on Social Networks: